Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414162033> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2414162033 endingPage "661" @default.
- W2414162033 startingPage "656" @default.
- W2414162033 abstract "To review the current utility and proper role of dornase alfa (recombinant human DNase or rhDNase), which has been approved for use in cystic fibrosis. Several aspects related to these issues are addressed including the drug's mechanism of action, administration and dosing, and clinical safety and efficacy. We also critically examine the agent's role in the treatment of cysti fibrosis and consider the controversies involved with its use.A MEDLINE search was conducted to identify pertinent literature, including review articles and clinical trials.Studies examining the efficacy and safety of dornase alfa in patients with cystic fibrosis.Results from published, prospective, randomized trials are presented and critiqued.Production of viscous respiratory secretion is a hallmark phenomenon of cystic fibrosis, leading to a variety of symptoms. Dornase alfa targets this symptom and decreases the viscosity of these secretions. Clinical trials have indicated a small but statistically significant improvement in forced expiratory volume in 1 second and forced vital capacity. Enhancement in a patient's dyspnea and quality of life has varied between the trials, with few of the studies noting no statistically significant improvement. Adverse reactions are minimal and did not result in any patient withdrawals from the trials. A positive impact on infection rates, length of hospitalization, and need for intravenous antibiotic therapy was noted in one trial. However, reports of similar results have not yet been published, and thus the clinical significance or impact of this phenomenon is not fully understood. Moreover, results of more long-term use and in patients whose conditions are less stable have yet to undergo the scrutiny of peer/editorial review. Administration of the drug, which must be maintained continuously, is relatively expensive.Dornase alfa appears to produce small but sustained improvements in lung function in patients with cystic fibrosis. It may also slow the progression of pulmonary disease. Infection rates appear to be reduced, which may well have important long-term consequences. However, evidence to date has not clarified the most appropriate use of dornase alfa in the treatment of cystic fibrosis. Whether quality of life is affected in a meaningful and measurable way is yet to be clarified. A trial of the drug in patients with cystic fibrosis who have obvious lung disease is reasonable, but continued treatment should be based on clear clinical response. Therefore, questions about the drug's exact role in the overall management of cystic fibrosis remain to be answered. Although benefits received may not prove to be cost-effective, long-term effects on disease progression may well justify use of this agent." @default.
- W2414162033 created "2016-06-24" @default.
- W2414162033 creator A5010384230 @default.
- W2414162033 creator A5039294778 @default.
- W2414162033 creator A5039827116 @default.
- W2414162033 creator A5072938619 @default.
- W2414162033 date "1996-06-01" @default.
- W2414162033 modified "2023-09-27" @default.
- W2414162033 title "The Role of Dornase Alfa in the Treatment of Cystic Fibrosis" @default.
- W2414162033 cites W175998601 @default.
- W2414162033 cites W1994295350 @default.
- W2414162033 cites W1997182007 @default.
- W2414162033 cites W2018869417 @default.
- W2414162033 cites W2023546954 @default.
- W2414162033 cites W2028171116 @default.
- W2414162033 cites W2031789064 @default.
- W2414162033 cites W2035561609 @default.
- W2414162033 cites W2074796851 @default.
- W2414162033 cites W2150399236 @default.
- W2414162033 cites W2333398204 @default.
- W2414162033 cites W2336714143 @default.
- W2414162033 cites W4297631468 @default.
- W2414162033 doi "https://doi.org/10.1177/106002809603000614" @default.
- W2414162033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8792953" @default.
- W2414162033 hasPublicationYear "1996" @default.
- W2414162033 type Work @default.
- W2414162033 sameAs 2414162033 @default.
- W2414162033 citedByCount "13" @default.
- W2414162033 countsByYear W24141620332017 @default.
- W2414162033 countsByYear W24141620332018 @default.
- W2414162033 countsByYear W24141620332021 @default.
- W2414162033 countsByYear W24141620332022 @default.
- W2414162033 crossrefType "journal-article" @default.
- W2414162033 hasAuthorship W2414162033A5010384230 @default.
- W2414162033 hasAuthorship W2414162033A5039294778 @default.
- W2414162033 hasAuthorship W2414162033A5039827116 @default.
- W2414162033 hasAuthorship W2414162033A5072938619 @default.
- W2414162033 hasConcept C126322002 @default.
- W2414162033 hasConcept C177713679 @default.
- W2414162033 hasConcept C197934379 @default.
- W2414162033 hasConcept C2776938444 @default.
- W2414162033 hasConcept C2777288759 @default.
- W2414162033 hasConcept C535046627 @default.
- W2414162033 hasConcept C71924100 @default.
- W2414162033 hasConceptScore W2414162033C126322002 @default.
- W2414162033 hasConceptScore W2414162033C177713679 @default.
- W2414162033 hasConceptScore W2414162033C197934379 @default.
- W2414162033 hasConceptScore W2414162033C2776938444 @default.
- W2414162033 hasConceptScore W2414162033C2777288759 @default.
- W2414162033 hasConceptScore W2414162033C535046627 @default.
- W2414162033 hasConceptScore W2414162033C71924100 @default.
- W2414162033 hasIssue "6" @default.
- W2414162033 hasLocation W24141620331 @default.
- W2414162033 hasLocation W24141620332 @default.
- W2414162033 hasOpenAccess W2414162033 @default.
- W2414162033 hasPrimaryLocation W24141620331 @default.
- W2414162033 hasRelatedWork W1993177358 @default.
- W2414162033 hasRelatedWork W2017550532 @default.
- W2414162033 hasRelatedWork W2026198808 @default.
- W2414162033 hasRelatedWork W2136148117 @default.
- W2414162033 hasRelatedWork W2418502454 @default.
- W2414162033 hasRelatedWork W2424357543 @default.
- W2414162033 hasRelatedWork W2947032946 @default.
- W2414162033 hasRelatedWork W3033165929 @default.
- W2414162033 hasRelatedWork W3034070945 @default.
- W2414162033 hasRelatedWork W4300716589 @default.
- W2414162033 hasVolume "30" @default.
- W2414162033 isParatext "false" @default.
- W2414162033 isRetracted "false" @default.
- W2414162033 magId "2414162033" @default.
- W2414162033 workType "article" @default.